RS20090389A - So 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-oktahidrobenzo (d)izoksazol-4-ona - Google Patents

So 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-oktahidrobenzo (d)izoksazol-4-ona

Info

Publication number
RS20090389A
RS20090389A RSP-2009/0389A RSP20090389A RS20090389A RS 20090389 A RS20090389 A RS 20090389A RS P20090389 A RSP20090389 A RS P20090389A RS 20090389 A RS20090389 A RS 20090389A
Authority
RS
Serbia
Prior art keywords
fumarate salt
fumarate
drug
compound
salt
Prior art date
Application number
RSP-2009/0389A
Other languages
English (en)
Serbian (sr)
Inventor
Fabio Neggiani
Laura Dini
Original Assignee
Abiogen Pharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma S.P.A. filed Critical Abiogen Pharma S.P.A.
Publication of RS20090389A publication Critical patent/RS20090389A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RSP-2009/0389A 2006-11-02 2007-10-31 So 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-oktahidrobenzo (d)izoksazol-4-ona RS20090389A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002102A ITMI20062102A1 (it) 2006-11-02 2006-11-02 Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
PCT/IB2007/003291 WO2008053325A1 (en) 2006-11-02 2007-10-31 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Publications (1)

Publication Number Publication Date
RS20090389A true RS20090389A (sr) 2010-12-31

Family

ID=39145485

Family Applications (2)

Application Number Title Priority Date Filing Date
RSP-2009/0389A RS20090389A (sr) 2006-11-02 2007-10-31 So 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-oktahidrobenzo (d)izoksazol-4-ona
RSP-2009/0388A RS20090388A (sr) 2006-11-02 2007-10-31 So 3 - benzil - 2 - metil - 2,3,3a,4,5,6,7,7a - oktahidrobenzo(d)izoksazol-4-ona

Family Applications After (1)

Application Number Title Priority Date Filing Date
RSP-2009/0388A RS20090388A (sr) 2006-11-02 2007-10-31 So 3 - benzil - 2 - metil - 2,3,3a,4,5,6,7,7a - oktahidrobenzo(d)izoksazol-4-ona

Country Status (20)

Country Link
US (2) US20100069450A1 (enExample)
EP (2) EP2094674B1 (enExample)
JP (2) JP2010509309A (enExample)
KR (2) KR20090082452A (enExample)
CN (2) CN101535281A (enExample)
AT (2) ATE502021T1 (enExample)
AU (2) AU2007315832A1 (enExample)
BR (2) BRPI0718392A2 (enExample)
CA (2) CA2667515A1 (enExample)
DE (2) DE602007013278D1 (enExample)
HR (2) HRP20090477A2 (enExample)
IL (2) IL198443A0 (enExample)
IT (1) ITMI20062102A1 (enExample)
MX (2) MX2009004294A (enExample)
NO (2) NO20092115L (enExample)
NZ (2) NZ577978A (enExample)
RS (2) RS20090389A (enExample)
RU (2) RU2009120724A (enExample)
WO (2) WO2008053326A1 (enExample)
ZA (2) ZA200903618B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112142A1 (en) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
US10131642B1 (en) * 2015-01-30 2018-11-20 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
CN101535281A (zh) 2009-09-16
EP2094675A1 (en) 2009-09-02
RU2009120724A (ru) 2010-12-10
WO2008053325A1 (en) 2008-05-08
DE602007013801D1 (de) 2011-05-19
HRP20090477A2 (hr) 2009-11-30
CA2667513A1 (en) 2008-05-08
JP2010509309A (ja) 2010-03-25
ZA200903618B (en) 2010-07-28
DE602007013278D1 (de) 2011-04-28
EP2094675B1 (en) 2011-04-06
NZ577978A (en) 2010-10-29
CA2667515A1 (en) 2008-05-08
ATE504578T1 (de) 2011-04-15
AU2007315832A1 (en) 2008-05-08
BRPI0718391A2 (pt) 2013-11-26
AU2007315833A1 (en) 2008-05-08
US20100069450A1 (en) 2010-03-18
US20100069451A1 (en) 2010-03-18
MX2009004294A (es) 2009-05-08
RS20090388A (sr) 2010-12-31
ITMI20062102A1 (it) 2008-05-03
KR20090077014A (ko) 2009-07-13
HRP20090470A2 (hr) 2009-11-30
JP2010509310A (ja) 2010-03-25
IL198444A0 (en) 2010-02-17
WO2008053326A1 (en) 2008-05-08
EP2094674B1 (en) 2011-03-16
NO20092114L (no) 2009-05-29
NO20092115L (no) 2009-05-29
IL198443A0 (en) 2010-02-17
RU2009120667A (ru) 2010-12-10
EP2094674A1 (en) 2009-09-02
CN101535282A (zh) 2009-09-16
ATE502021T1 (de) 2011-04-15
BRPI0718392A2 (pt) 2013-11-26
ZA200903810B (en) 2010-07-28
NZ577311A (en) 2010-10-29
MX2009004293A (es) 2009-05-08
KR20090082452A (ko) 2009-07-30

Similar Documents

Publication Publication Date Title
EP0506532A1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2809730A1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
RS20090389A (sr) So 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-oktahidrobenzo (d)izoksazol-4-ona
EP0343050B1 (fr) Dérivés de phényl-6 pipérazinyl-alkyl-3 1H,3H-pyrimidinedione-2,4, leur préparation et leur application en thérapeutique
FR2776660A1 (fr) Diazepino-indoles de phosphodiesterases iv
DE1795022C3 (de) Lysergsäurederivate
EP0082040B1 (fr) Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
KR102381002B1 (ko) 벤조산 유도체 및 이를 유효성분으로 함유하는 자가면역질환 예방 또는 치료용 조성물
MC1576A1 (fr) Derives d'imidazole
FR2480602A1 (fr) Hexahydro-pyrimido(1,2-a)azepines 3-substituees a titre de medicaments
EP0005422A2 (fr) Dérivés d'acides oméga-dialkylalkanoiques, leurs procédés de préparation ainsi que leur utilisation en thérapeutique
FR2464952A1 (fr) Nouveaux derives thienyliques, leur procede de preparation et leur application comme medicaments
MC513A1 (fr) Nouveaux dérivés de la semicarbazide et leur preparation
EP0311467A2 (fr) Utilisation de dérivés de pyrrolo[3,2,1-hi]indole pour obtenir un médicament destiné au traitement du diabète
CH685700A5 (fr) Esters nitriques de 1,2-benzo-isothiazolyl-3(2H)one-1,1-dioxyde, procédé de préparation de ces esters et médicaments contenant ces esters.